Skip to main content
Log in

Einsatz von Genhybridisierungstests und DNA-Sequenzierung bei metastasiertem Mammakarzinom

Ergebnis einer prospektiven Multizenterstudie (SAFIRO1/UNICANCER)

First results of a multicenter molecular screening study to identify abnormalities in patients with the aim of individualized therapy in dependency of genomic alterations (SAFIR01/UNICANCER)

  • Journal Club
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Beroukhim R, Mermel CH, Porter D (2010) The landscape of somatic copy-number alteration across human cancers. Nature 463:899–905

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  2. Brunetto AT, Sarker D, Papdator-Pastos D (2010) A retrospective analysis of clinical outcome of patients with chemo-refractory metastatic breast cancer treated in a single institution phase I unit. Br J Cancer 103:607–612

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  3. Curtis C, Shah SP, Chin SF (2012) The genomic und transcriptomic architecture of 2.000 breast tumours reveals novel subgroups. Nature 486:346–352

    CAS  PubMed Central  PubMed  Google Scholar 

  4. Stephens PJ, Tapey PS, Davies H (2012) The landscape of cancer genes and mutational process in breast cancer. Nature 486:400–404

    CAS  PubMed Central  PubMed  Google Scholar 

Download references

Einhaltung der ethischen Richtlinien

Interessenkonflikt. M. Becker-Schiebe gibt an, dass kein Interessenkonflikt besteht. Das vorliegende Manuskript enthält keine Studien an Menschen und Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E.-M. Grischke.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Grischke, EM. Einsatz von Genhybridisierungstests und DNA-Sequenzierung bei metastasiertem Mammakarzinom. Onkologe 20, 778–779 (2014). https://doi.org/10.1007/s00761-014-2727-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-014-2727-x

Navigation